Cheryl Zimberlin

Direktor/Vorstandsmitglied bei

Indi Molecular, Inc.

Commercial Services

Health Technology

Finance

Profil

Cheryl Zimberlin is currently the Director at Indi Molecular, Inc. and the Principal at Merck Ventures BV.
She previously worked as a Member-Supervisory Board at Vaximm AG.

Aktive Positionen von Cheryl Zimberlin

Unternehmen	Position	Beginn
Merck Ventures BV Merck Ventures BV Investment ManagersFinance Merck Ventures invests in companies located in the Netherlands. The firm targets companies operating in the fields of healthcare, healthcare drug development, life science tools, electronics and frontier technology & sustainability sectors. It provides financing for early stage capital requirements.	Private Equity Investor	01.04.2019
Indi Molecular, Inc. Indi Molecular, Inc. BiotechnologyHealth Technology Develops a synthetic class of diagnostic and therapeutic agents	Direktor/Vorstandsmitglied	-

Alle aktiven Positionen von Cheryl Zimberlin

Ehemalige bekannte Positionen von Cheryl Zimberlin

Unternehmen	Position	Ende
Vaximm AG Vaximm AG Miscellaneous Commercial ServicesCommercial Services Develops immunotherapies for cancer treatment	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Cheryl Zimberlin im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Cheryl Zimberlin im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	3
Vaximm AG Vaximm AG Miscellaneous Commercial ServicesCommercial Services Develops immunotherapies for cancer treatment	Commercial Services
Indi Molecular, Inc. Indi Molecular, Inc. BiotechnologyHealth Technology Develops a synthetic class of diagnostic and therapeutic agents	Health Technology
Merck Ventures BV Merck Ventures BV Investment ManagersFinance Merck Ventures invests in companies located in the Netherlands. The firm targets companies operating in the fields of healthcare, healthcare drug development, life science tools, electronics and frontier technology & sustainability sectors. It provides financing for early stage capital requirements.	Finance